Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Anika Therapeutics Inc. logo

Anika Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

25.64
 
USD
  
0.24
  
(0.94%)
Optionable: Yes  Market Cap: 379 M  90-day average vol: 80,325

Previous close: 25.4  Open: 25.5  Bid: 16.22  Ask: 26.0
52 week range    
16.54   
   28.67
Peers   
MDT / 
DYNT / 
SYK / 
JNJ / 
HALO / 
Last updated: Tuesday 21st May 2024
53
MarketXLS Rank
60
Value
46
Technical
55
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ANIK Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-2 M-2 M-1 M-1 M-1000000.0-1000000.08 M91 M82 M75 M
Basic EPS from continuing operations1.93-1.690.29-1.02
Basic EPS total1.462.612.062.222.181.31.93-1.690.29-1.02
Basic weighted shares outstanding14 M15 M15 M15 M15 M14 M14 M14 M14 M15 M
Cost of sales-23 M-21 M-21 M-24 M-27 M-31 M29 M61 M65 M63 M
Depreciation-3 M-3 M-3 M-3 M-3 M-5 M5 M6 M7 M7 M
DepreciationAndAmortization-3 M-3 M-3 M-3 M-3 M-5 M5 M6 M7 M7 M
Diluted EPS total1.392.512.012.152.111.271.89-1.690.28-1.02
Diluted normalized net income/share1.89-1.690.28-1.02
Diluted weighted shares outstanding15 M15 M15 M15 M15 M15 M14 M14 M15 M15 M
GeneralAndAdministrativeExpense-1 M-1 M-1 M-1 M-2 M-2 M35 M60 M74 M85 M
Gross operating profit52 M85 M72 M79 M86 M74 M86 M69 M83 M94 M
ImpairmentOfCapitalAssets389000.043 M
Income before tax32 M62 M48 M51 M46 M23 M36 M-29 M2 M-19 M
Income restructuring and M&A-286843.0-7 M23 M
Income taxes12 M23 M17 M18 M14 M4 M9 M-5 M-2 M-4 M
Interest income-127186.058000.0120000.0263000.0473000.01 M2 M-302000.0-188000.0654000.0
InterestExpenseNonOperating25000.019000.011000.0
MiscOtherSpecialCharges900000.0
Net income from total operations21 M38 M31 M33 M32 M19 M27 M-24 M4 M-15 M
NetIncomeCommonStockholders21 M38 M31 M33 M32 M19 M27 M-24 M4 M-15 M
NetIncomeContinuousOperations21 M38 M31 M33 M32 M19 M27 M-24 M4 M-15 M
NetIncomeDiscontinuousOperations10 M
NetNonOperatingInterestIncomeExpense-127186.058000.0120000.0263000.0473000.01 M2 M-302000.0-188000.0654000.0
Operating income32 M61 M48 M51 M46 M22 M34 M-28 M3 M-19 M
Operating income before depreciation (EBITDA)37 M66 M52 M55 M50 M29 M43 M-3 M25 M-2 M
OperatingExpense20 M23 M24 M29 M40 M53 M52 M83 M101 M113 M
Other income net-377000.0-3000.0-16000.0-906000.0-360000.0-158 M-29 M-21 M-180000.0
OtherGandA-1 M-1 M-1 M-1 M-2 M-2 M35 M60 M74 M85 M
OtherImpairmentOfCapitalAssets-697000.0
OtherOperatingExpenses-238071.0-38000.0-52000.0-2 M-57000.02 M3 M3 M
OtherWriteOff-377000.0-3000.0-16000.0-6000.0-360000.0-505000.0-86000.0-92000.0-180000.0
ProvisionForGainLossOnDisposal10 M
RentAndLandingFees-1 M-1 M-1 M-1 M-2 M-2 M
Research & development expense7 M8 M9 M11 M19 M18 M17 M23 M27 M28 M
ResearchExpense7 M8 M9 M11 M19 M18 M17 M23 M27 M28 M
RestructringAndMnAIncome-286843.0-7 M23 M
Revenue per share-2 M-2 M-1 M-1 M-1000000.0-1000000.08 M91 M83 M75 M
SalariesAndWages-2 M-3 M-2 M-3 M-6 M-11 M-100000.0-200000.0-100000.0-1 M
Selling Gen & administrative expense13 M15 M15 M18 M22 M34 M35 M60 M74 M85 M
SellingAndMarketingExpense13 M15 M15 M18 M22 M34 M
SellingExpense13 M15 M15 M18 M22 M34 M
Special income/charges286843.07 M-43 M
Total Income available for interest expense (EBIT)32 M62 M48 M51 M46 M23 M36 M-29 M2 M-19 M
Total common shares outstanding14 M15 M14 M15 M15 M14 M14 M14 M14 M15 M
Total net income21 M38 M31 M33 M32 M19 M27 M-24 M4 M-15 M
Total ordinary shares15 M15 M15 M15 M15 M15 M15 M15 M15 M15 M
Total revenues75 M106 M93 M103 M113 M106 M115 M130 M148 M156 M
TotalExpenses-3 M2 M3 M5 M13 M21 M80 M145 M166 M176 M
TotalRevenue72 M75 M88 M103 M113 M106 M115 M130 M148 M156 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University